Manuel Ramos Casals-rekin lankidetzan egindako argitalpenak (7)

2021

  1. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    Joint Bone Spine, Vol. 88, Núm. 6

2019

  1. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

    Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106

  2. The Big Data Sjögren consortium: A project for a new data science era

    Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23

2017

  1. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome

    Journal of Hematology and Oncology, Vol. 10, Núm. 1

2016

  1. Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355

2009

  1. Chronic hepatitis B virus infection in Sjögren's syndrome. Prevalence and clinical significance in 603 patients

    Autoimmunity Reviews, Vol. 8, Núm. 7, pp. 616-620

2004

  1. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: Prevalence and clinical significance in 667 patients

    Lupus, Vol. 13, Núm. 10, pp. 777-783